These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32361913)

  • 1. 3'UTR Diversity: Expanding Repertoire of RNA Alterations in Human mRNAs.
    Hong D; Jeong S
    Mol Cells; 2023 Jan; 46(1):48-56. PubMed ID: 36697237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splicing-accessible coding 3'UTRs control protein stability and interaction networks.
    Preussner M; Gao Q; Morrison E; Herdt O; Finkernagel F; Schumann M; Krause E; Freund C; Chen W; Heyd F
    Genome Biol; 2020 Jul; 21(1):186. PubMed ID: 32727563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative analysis of somatic mutations altering microRNA targeting in cancer genomes.
    Ziebarth JD; Bhattacharya A; Cui Y
    PLoS One; 2012; 7(10):e47137. PubMed ID: 23091610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifactorial analysis of terminator performance on heterologous gene expression in Physcomitrella.
    Niederau PA; Eglé P; Willig S; Parsons J; Hoernstein SNW; Decker EL; Reski R
    Plant Cell Rep; 2024 Jan; 43(2):43. PubMed ID: 38246952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs and other mechanisms regulate interleukin-17 cytokines and receptors.
    Mai J; Virtue A; Maley E; Tran T; Yin Y; Meng S; Pansuria M; Jiang X; Wang H; Yang XF
    Front Biosci (Elite Ed); 2012 Jan; 4(4):1478-95. PubMed ID: 22201969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Massively parallel screen uncovers many rare 3' UTR variants regulating mRNA abundance of cancer driver genes.
    Fu T; Amoah K; Chan TW; Bahn JH; Lee JH; Terrazas S; Chong R; Kosuri S; Xiao X
    Nat Commun; 2024 Apr; 15(1):3335. PubMed ID: 38637555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA interactions with disordered regions control protein activity.
    Luo Y; Pratihar S; Horste EH; Mitschka S; Mey ASJS; Al-Hashimi HM; Mayr C
    bioRxiv; 2023 Feb; ():. PubMed ID: 36824771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA ac
    Tao L; Lu Y; Chen Z; Ge L; He J; Peng J; Wang H
    Sci China Life Sci; 2024 Apr; 67(4):832-835. PubMed ID: 38324129
    [No Abstract]   [Full Text] [Related]  

  • 9. Emerging Roles for 3' UTRs in Neurons.
    Bae B; Miura P
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the frequency of a TP53 polyadenylation signal variant in tumor DNA from patients diagnosed with lung adenocarcinomas, sarcomas and uterine leiomyomas.
    Vieira IA; Viola GD; Pezzi EH; Kowalski TW; Fernandes BV; Andreis TF; Bom N; Sonnenstrahl G; Rocha YMA; Corrêa BDS; Donatti LM; Sant'Anna GDS; Corleta HVE; Brum IS; Rosset C; Vianna FSL; Macedo GS; Palmero EI; Ashton-Prolla P
    Genet Mol Biol; 2024; 46(3 Suppl 1):e20230133. PubMed ID: 38252059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of mRNA 3'-end isoforms in cervical and ovarian cancers.
    Dioken DN; Ozgul I; Koksal Bicakci G; Gol K; Can T; Erson-Bensan AE
    Heliyon; 2023 Sep; 9(9):e20035. PubMed ID: 37810050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 3' Non-Coding Sequence Negatively Regulates PD-L1 Expression, and Its Regulators Are Systematically Identified in Pan-Cancer.
    Chen Z; Pi H; Zheng W; Guo X; Shi C; Wang Z; Zhang J; Qu X; Liu L; Shen H; Lu Y; Chen M; Zhang W; Sun R; Fan Y
    Genes (Basel); 2023 Aug; 14(8):. PubMed ID: 37628671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential impact of BRAFV600E isoforms on tumorigenesis in a zebrafish model of melanoma.
    De Paolo R; Sarti S; Bernardi S; Cucco F; Tavosanis A; Pitto L; Poliseno L
    Cell Biosci; 2023 Jul; 13(1):121. PubMed ID: 37393328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PARP1 negatively regulates MAPK signaling by impairing BRAF-X1 translation.
    Marranci A; Prantera A; Masotti S; De Paolo R; Baldanzi C; Podda MS; Mero S; Vitiello M; Franchin C; Laezza M; Comelli L; Arrigoni G; Cervelli T; Del Pozzo G; Poliseno L
    J Hematol Oncol; 2023 Apr; 16(1):33. PubMed ID: 37013641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss-of-function mutation in Pcsk1 increases serum APOA1 level and LCAT activity in mice.
    Khan AA; Kim N; Korstanje R; Choi S
    Lab Anim Res; 2022 Jan; 38(1):1. PubMed ID: 34996527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an mRNA isoform switch for HNRNPA1 in breast cancers.
    Erdem M; Ozgul İ; Dioken DN; Gurcuoglu I; Guntekin Ergun S; Cetin-Atalay R; Can T; Erson-Bensan AE
    Sci Rep; 2021 Dec; 11(1):24444. PubMed ID: 34961772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-Stranded RNA Structural Elements Holding the Key to Translational Regulation in Cancer: The Case of Editing in RNA-Binding Motif Protein 8A.
    Abukar A; Wipplinger M; Hariharan A; Sun S; Ronner M; Sculco M; Okonska A; Kresoja-Rakic J; Rehrauer H; Qi W; Beusechem VWV; Felley-Bosco E
    Cells; 2021 Dec; 10(12):. PubMed ID: 34944051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Coding Variants in Cancer: Mechanistic Insights and Clinical Potential for Personalized Medicine.
    Lange M; Begolli R; Giakountis A
    Noncoding RNA; 2021 Aug; 7(3):. PubMed ID: 34449663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.
    Erson-Bensan AE
    Cancer Metastasis Rev; 2020 Sep; 39(3):887-901. PubMed ID: 32361913
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.